Physician profile
Peter D Stein
NPI 1215977277
$130,999.71
in general payments reported to CMS, 2019-2025
14 companies · $34K in 2025
The $34K reported for 2025 was more than what 97% of Hand Surgery providers received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $16K · 2020: $9,378 · 2021: $31K · 2022: $13K · 2023: $13K · 2024: $15K · 2025: $34K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $51K · Travel and Lodging: $8,570 · Food and Beverage: $2,397.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50,935.00 |
| Travel and Lodging | $8,569.72 |
| Food and Beverage | $2,397.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo Pharmaceuticals INC. | $83,629.36 | 2019-2024 | Xiaflex |
| Endo USA, INC. | $45,024.23 | 2024-2025 | Xiaflex |
| Medartis INC. | $1,470.74 | 2019-2022 | |
| Bioventus LLC | $448.03 | 2019-2025 | Durolane, Durolane |
| Hitachi Healthcare Americas Corp. | $175.68 | 2019 | |
| Orthofix Medical, INC. | $67.79 | 2019 | |
| Suvon Surgical LLC | $62.65 | 2025 | |
| Si-Bone, INC. | $21.03 | 2019 | |
| Eagle Pharmaceuticals, INC. | $19.69 | 2023 | |
| Molnlycke Health Care US, LLC | $19.15 | 2023 | Avance, Mepilex Border Post-Op Ag |
| Ferring Pharmaceuticals INC. | $17.92 | 2021 | |
| Stryker Corporation | $17.38 | 2023 | Gamma |
| Depuy Synthes Sales INC. | $14.47 | 2024 | Orthovisc, Monovisc |
| Nevro Corp. | $11.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Stein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.